“Investigation of dual anti-HIV/HSV activity of oxoquinoline-acylhydrazone derivatives by molecular docking”, Braz. J. Pharm. Sci., vol. 59, p. e23263, Nov. 2023, doi: 10.1590/s2175-97902023e23263.